Taiwan FDA registration 1e1c3720570c51b2c15238420e0c4df6
BioMérieurate assay reagent
TW: 生物梅里埃尿酸測定試劑
Taiwan·BIOMERIEUX S.A.(IN MARCY)·Registered Dec 10, 2005 – Dec 10, 2010CancelledRegistration details
- Analysis ID
- 1e1c3720570c51b2c15238420e0c4df6
- Customs Code
- DHA00601540201
Company information
- Manufacturer
- BIOMERIEUX S.A.(IN MARCY)
- Manufacturer Country
- France
- Authorized Representative
- BIOMERIEUX CHINA LIMITED, TAIWAN BRANCH (HONG KONG)
Product details
- Intended Use
- to catalyze the amount of uric acid in human urine, serum, and blood per quantitative.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1775 尿酸試驗系統
- Import Information
- import
Dates and status
- Registration Date
- Dec 10, 2005
- Expiry Date
- Dec 10, 2010
- Cancellation Date
- Nov 27, 2012
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for BioMérieurate assay reagent in Taiwan's medical device market through Pure Global AI's free database. is registered under number 1e1c3720570c51b2c15238420e0c4df6 and manufactured by BIOMERIEUX S.A.(IN MARCY). The authorized representative in Taiwan is BIOMERIEUX CHINA LIMITED, TAIWAN BRANCH (HONG KONG).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices